Cegedim SA
PAR:CGM

Watchlist Manager
Cegedim SA Logo
Cegedim SA
PAR:CGM
Watchlist
Price: 10.4 EUR -1.89% Market Closed
Market Cap: 146.6m EUR
Section:
 

Relative Value

The Relative Value of one CGM stock under the Base Case scenario is 43.16 EUR. Compared to the current market price of 10.4 EUR, Cegedim SA is Undervalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CGM Relative Value
Base Case
43.16 EUR
Undervaluation 76%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
92
vs Industry
85
Median 3Y
0.3
Median 5Y
0.4
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
5
Median 3Y
14.1
Median 5Y
16.8
Industry
22.4
More Details
1.4
P/OCF
P/OCF
Price to OCF
1.4
vs History
92
vs Industry
54
Median 3Y
1.9
Median 5Y
2.7
Industry
14.4
More Details
5.9
P/FCFE
P/FCFE
Price to FCFE
5.9
vs History
53
vs Industry
40
Median 3Y
6
Median 5Y
6.5
Industry
21.7
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
92
vs Industry
73
Median 3Y
0.7
Median 5Y
0.9
Industry
2.2
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
90
vs Industry
76
Median 3Y
0.7
Median 5Y
0.8
Industry
2.5
More Details
3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3
vs History
92
vs Industry
55
Median 3Y
3.4
Median 5Y
4.2
Industry
5.1
More Details
3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3
vs History
90
vs Industry
50
Median 3Y
3.8
Median 5Y
4.3
Industry
12
More Details
10.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.5
vs History
88
vs Industry
22
Median 3Y
18.7
Median 5Y
14.9
Industry
16.9
More Details
3.9
EV/OCF
EV/OCF
Enterprise Value to OCF
3.9
vs History
92
vs Industry
50
Median 3Y
4.3
Median 5Y
4.7
Industry
14.5
More Details
33.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
33.1
vs History
22
vs Industry
14
Median 3Y
32.2
Median 5Y
18.6
Industry
18.6
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
84
vs Industry
79
Median 3Y
0.5
Median 5Y
0.6
Industry
1.8
More Details

Multiples Across Competitors

CGM Competitors Multiples
Cegedim SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Cegedim SA
PAR:CGM
142.6m EUR 0.2 -9.7 3 10.5
US
Veeva Systems Inc
NYSE:VEEV
36.5B USD 11.8 42.4 32.1 33.5
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
22.7B AUD 103 197.1 136.2 136.2
JP
M3 Inc
TSE:2413
1.4T JPY 4.4 31.5 16 19.8
US
Doximity Inc
NYSE:DOCS
8.2B USD 13.2 32.4 28.4 29.7
US
Waystar Holding Corp
NASDAQ:WAY
5.7B USD 5.5 51.6 17.1 26.9
SE
Sectra AB
STO:SECT B
48.8B SEK 22.9 83.3 -116.9 -116.9
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
290.9B INR 10.9 59.9 37.2 43.5
CN
Winning Health Technology Group Co Ltd
SZSE:300253
20.3B CNY 9.4 -65.9 -130.4 -130.4
US
Inspire Medical Systems Inc
NYSE:INSP
2.8B USD 3.2 63 50.3 67.6
P/E Multiple
Earnings Growth PEG
FR
Cegedim SA
PAR:CGM
Average P/E: 68.2
Negative Multiple: -9.7 		N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
42.4
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
197.1
32%
6.2
JP
M3 Inc
TSE:2413
31.5
16%
2
US
Doximity Inc
NYSE:DOCS
32.4
18%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
51.6
N/A N/A
SE
Sectra AB
STO:SECT B
83.3
28%
3
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
59.9
30%
2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -65.9
92%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
63
13%
4.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Cegedim SA
PAR:CGM
Average EV/EBITDA: 38
3
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
32.1
39%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
136.2
32%
4.3
JP
M3 Inc
TSE:2413
16
14%
1.1
US
Doximity Inc
NYSE:DOCS
28.4
23%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
17.1
24%
0.7
SE
Sectra AB
STO:SECT B
Negative Multiple: -116.9 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
37.2
24%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -130.4
36%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
50.3
80%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Cegedim SA
PAR:CGM
Average EV/EBIT: 45.6
10.5
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.5
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
136.2
31%
4.4
JP
M3 Inc
TSE:2413
19.8
N/A N/A
US
Doximity Inc
NYSE:DOCS
29.7
25%
1.2
US
W
Waystar Holding Corp
NASDAQ:WAY
26.9
56%
0.5
SE
Sectra AB
STO:SECT B
Negative Multiple: -116.9 N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
43.5
27%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -130.4
47%
N/A
US
Inspire Medical Systems Inc
NYSE:INSP
67.6
34%
2

See Also

Summary
CGM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGM stock valuation using valuation multiples.
Wall Street Estimates
CGM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.